FHB
ARCT icon

First Hawaiian Bank’s Arcturus Therapeutics ARCT Stock Holding History

First Hawaiian Bank’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-16,284
Closed -$699K – 812
2020
Q3 		$699K Sell
16,284
-1,164
-7% -$57.8K 0.04% 331
2020
Q2 		$816K Buy
+17,448
New +$601K 0.04% 303

Other funds holding ARCT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

First Hawaiian Bank's ARCT Position: Q4 2020 in Review

First Hawaiian Bank sold out of Arcturus Therapeutics (ARCT) in Q4 2020, closing a stake of 16,284 shares — an estimated $699K sold.

First Hawaiian Bank first reported a position in ARCT in Q2 2020 and held it in 2 quarters. The position peaked at $816K in Q2 2020. 135 funds tracked by Wall St. Rank hold ARCT as of Q4 2020.

  • First Hawaiian Bank reported no remaining Arcturus Therapeutics position as of Q4 2020 after selling out during the quarter.
  • First Hawaiian Bank sold 16,284 Arcturus Therapeutics shares in Q4 2020, an estimated $699K.
  • First Hawaiian Bank first reported a position in Arcturus Therapeutics in Q2 2020 and held it in 2 quarters.
  • First Hawaiian Bank's Arcturus Therapeutics position peaked at $816K in Q2 2020.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q4 2020.

Based on First Hawaiian Bank's 13F filing for Q4 2020, filed 12 Jan 2021.